Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery
NCT ID: NCT05588037
Last Updated: 2022-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2017-01-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Outcomes Between Femtosecond Laser-Assisted and Conventional Phacoemulsification in Fuchs Endothelial Corneal Dystrophy Patients With Cataracts
NCT06966167
Comparison of Femtosecond Laser Assisted Cataract Surgery to Conventional Phacoemulsification Cataract Surgery
NCT02096627
A Prospective Multicenter Study of Different Surgical Methods in the Treatment of High Myopic Macular Schisis
NCT04146350
Subfoveal Choroidal Thickness After Surgery for Age-related Cataracts
NCT02895074
Posterior Capsulotomy in Cataract Complicated With Primary Posterior Capsule Opacification.
NCT03701139
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RRD group
to evaluate the efficacy and complications of a new minimally invasive vitreoretinal surgery combined with FLACS in the treatment of rhegmatogenous retinal detachment complicated with cataract.
FLACS +PPV+IOL + air
The procedures are combined the FLACS +PPV+IOL + air.
ERM group
to evaluate the efficacy and complications of a new minimally invasive vitreoretinal surgery combined with FLACS in the treatment of epiretinal membrane complicated with cataract.
FLACS +PPV+IOL + epiretinal membrane peeling + Ozurdex
The procedures are combined the FLACS +PPV+IOL + epiretinal membrane peeling + Ozurdex.
MH group
to evaluate the efficacy and complications of a new minimally invasive vitreoretinal surgery combined with FLACS in the treatment of macular hole complicated with cataract.
FLACS + PPV+IOL + internal limiting membrane peeling + air
The procedures are combined the FLACS + PPV+IOL + internal limiting membrane peeling + air.
Vitreous cloudy group
to evaluate the efficacy and complications of a new minimally invasive vitreoretinal surgery combined with FLACS in the treatment of vitreous opacity complicated with cataract.
FLACS + PPV+IOL
The procedures are combined the FLACS + PPV+IOL.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FLACS +PPV+IOL + air
The procedures are combined the FLACS +PPV+IOL + air.
FLACS +PPV+IOL + epiretinal membrane peeling + Ozurdex
The procedures are combined the FLACS +PPV+IOL + epiretinal membrane peeling + Ozurdex.
FLACS + PPV+IOL + internal limiting membrane peeling + air
The procedures are combined the FLACS + PPV+IOL + internal limiting membrane peeling + air.
FLACS + PPV+IOL
The procedures are combined the FLACS + PPV+IOL.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ERM with cataract
* MH with cataract
* Vitreous opacity with cataract
Exclusion Criteria
* ocular trauma
* endophthalmitis
* uveitis
* glaucoma
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aier School of Ophthalmology, Central South University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wensheng Li
Role: STUDY_CHAIR
Aier Ophthalmology School of Central South University; Shanghai Aier Eye Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jiasong Yang
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHIRB2018019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.